About Centaur Pharmaceuticals
Centaur Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1978. Branded formulations and APIs are developed and manufactured. It operates on a Professional Services and Reseller / Distribution model. Centaur Pharmaceuticals has raised $7 million across 1 funding round from investors including SIDBI Venture Capital. The company has 3,523 employees. Centaur Pharmaceuticals was last valued at $22.55 million in May 2008. Its website centaurpharma.com draws about 31 thousand monthly visits. Its Indian entity Centaur Pharmaceuticals Private Limited reported revenue of ₹1,060 Cr. Centaur Pharmaceuticals offers products and services including API Solutions, Formulations, and Clinical Research. Its focus areas include Pharmaceuticals and Drug Manufacturing. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.
Company details
Centaur Pharmaceuticals is involved in the development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms (FDF). The company operates across various therapeutic areas including ENT, pediatrics, ophthalmology, neurology, nephrology, diabetology, and cardiology. Comprehensive solutions are provided through synergies in RD, clinical research, and contract research and manufacturing services (CRAM). Facilities are maintained in multiple locations across India to support its integrated pharmaceutical value chain. End-to-end solutions are offered to prestigious partners in the global pharmaceutical industry.
- Headquarters Mumbai, India
- Employees 3,523
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Pharmacy
- Phone•••• ••••
- Website centaurpharma.com
- Social LinkedIn X Facebook
- Legal Name Centaur Pharmaceuticals Pvt. Ltd.
- Date of Incorporation 15 Oct, 1980
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,060 Cr
FY 2025 · +22% YoY
- Net Profit₹190 Cr
FY 2025 · 18% margin
- EBITDA₹294 Cr
FY 2025 · 28% margin
- Total Equity Funding$7M (USD)
in 1 rounds
- Latest Funding Round$7M (USD), Series A
May 2008
- Investors
- Employee Count3,523
Associated legal entities of Centaur Pharmaceuticals
Centaur Pharmaceuticals operates through Centaur Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Centaur Pharmaceuticals Private Limited CIN U24230MH1980PTC023291 | Active | 15 Oct 1980 | Mumbai, Maharashtra | ₹1,060 Cr | 3,274 | 8 | View details |
Products & Services of Centaur Pharmaceuticals
Centaur Pharmaceuticals offers a comprehensive portfolio of products and services, including API Solutions, Formulations, and Clinical Research.
Active pharmaceutical ingredients are developed for drug manufacturing.
Finished dosage forms are produced for various treatments.
Clinical research services are provided for drug development.
Funding Insights of Centaur Pharmaceuticals
Centaur Pharmaceuticals has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Series A round of $7 million completed in May 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7M
- Total Rounds 1
- Last Round Series A — $7M
- First Round $7M
(May 2008)
- Investors Count 1
All 1 funding rounds of Centaur Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2008 | $7M | Series A | $22.55M | SIDBI Venture Capital | – |
| Date | Valuation | Stage |
|---|---|---|
| May 2008 | $22.55M | •••••••• |
Last known valuation $22.55M (May 2008). 1 investors in total: 1 institutional.
Investors in Centaur Pharmaceuticals
Centaur Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SIDBI Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital management for SMEs and startups in India. | 1999 | sidbiventure.co.in | Mumbai, India |
Investor details for Centaur Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Centaur Pharmaceuticals Private Limited (Centaur Pharmaceuticals)
Centaur Pharmaceuticals Private Limited is the primary company behind Centaur Pharmaceuticals. The board of Centaur Pharmaceuticals Private Limited currently have 7 directors; the longest-serving is Shivanand Dattatray Sawant, appointed in 1980. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shivanand Dattatray Sawant DIN 00407965 | Managing Director | 15 Oct 1980 | 46 yrs | Centaur Pharmaceuticals Private Limited |
| Shreekant Dattathray Sawant DIN 00745968 | Managing Director | 01 Aug 2008 | 18 yrs 3 mo | Centaur Pharmaceuticals Private Limited |
| Smita Abhayakumar Phal DIN 02887382 | Whole-time director | 22 Jun 2011 | 15 yrs 4 mo | Centaur Pharmaceuticals Private Limited |
| Rakhi Shridhar Kadam DIN 02898330 | Whole-time director | 14 Sep 2015 | 11 yrs 2 mo | Centaur Pharmaceuticals Private Limited |
| Sharadchandra Damodar Abhyankar DIN 00108866 | Director | 11 Aug 2016 | 10 yrs 3 mo | Centaur Pharmaceuticals Private Limited |
| Albert Tauro DIN 01860786 | Director | 11 Aug 2016 | 10 yrs 3 mo | Centaur Pharmaceuticals Private Limited |
| Supriya Samar Desai DIN 07499177 | Whole-time director | 21 Dec 2021 | 4 yrs 10 mo | Centaur Pharmaceuticals Private Limited |
People of Centaur Pharmaceuticals
32 people are tracked at Centaur Pharmaceuticals (7 in leadership, 25 in team); the tracked headcount is 3,523.
| Name | Role | Group |
|---|---|---|
Vipin Bongade | Assistant General Manager | Leadership |
Mukesh Sehgal | Associate Vice President | Leadership |
Abhinay Ajgaonkar | Head Of Quality Assurance | Leadership |
Dr. Shamkant Shimpi | Senior Vice-president Research And Development | Leadership |
Anil Naik | CEO and Founder | Leadership |
Dr. Mayuresh Kiran | Vice President And Head - Medical Services And Pharmacovigilance | Leadership |
Arun Kshirsagar | VP - Sales & Marketing (apis) | Leadership |
Hadi Mudasir | Scientific Communication Executive | Team |
Pratiksha Pandagale | Officer: Medical Services | Team |
Pramita Waghambare | Research Associate - Pharmacovigilance | Team |
Mayur Padiyar | Assistant Manager Exports ( API Sales & Marketing ) | Team |
Rajesh Chavan | Associate Researcher | Team |
Gaurav Kumar | Medical Representative | Team |
Pallavi Chaurasia | Business Development - North America And Canada | Team |
Prakash Narayan | Regional Manager | Team |
Kishor Biradar | Formulation Scientist | Team |
Sandip Katke | Associate Researcher | Team |
Rahul Kuwar | Senior Account Executive | Team |
Prasad Parte | Manager- Secondary Sales & Statistics | Team |
Vaibhav Bhosale | Researcher | Team |
12 more people are available in the full profile.
Complete people profiles for Centaur Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Centaur Pharmaceuticals
Figures of Centaur Pharmaceuticals Private Limited, the primary company behind Centaur Pharmaceuticals, for FY 2025. Revenue was ₹1,060 Cr (+22% year on year). Net profit was ₹190 Cr (18% margin). EBITDA was ₹294 Cr (28% margin). Revenue has grown at a compounded annual rate of +4% over three years and +7% over five years.
- ₹1,060 CrRevenue · FY 2025 · +22% YoY
- ₹190 CrNet profit · 18% margin
- ₹294 CrEBITDA · 28% margin
- ₹18.50 CrPaid-up capital
- 3,274Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Centaur Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Centaur Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Centaur Pharmaceuticals
3 dated milestones of Centaur Pharmaceuticals across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Centaur Pharmaceuticals is founded.
- Funding First funding round of $7.0M.
- Milestone Reaches Minicorn status.
Competitors of Centaur Pharmaceuticals
Centaur Pharmaceuticals has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed competitors of Centaur Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Centaur Pharmaceuticals
The website of Centaur Pharmaceuticals (centaurpharma.com) receives about 30.6K visits a month and ranks #1,329,622 among all websites worldwide, #2,123 in Pharmacy.
- Monthly visits30.6K
▲ 58.2% vs previous month
- Unique visitors9.7K
per month
- Global rank#1,329,622
among all websites
- Category rank#2,123
Health · Pharmacy
- Bounce rate44%
- Pages per visit2.1
- Average visit54 sec
- DevicesDesktop 16% · Mobile 84%
Websites whose visitors overlap most with Centaur Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| torquepharma.com | 100% | 24.9K | #1,830,907 | View details | |
| pharmatutor.org | 91% | #304,550 | View details | ||
| advacarepharma.com | 85% | 680.7K | #373,777 | View details | |
| leeford.in | 84% | 93.2K | #393,787 | View details | |
| medkart.in | 81% | 934.6K | #66,952 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Centaur Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Centaur Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Centaur Pharmaceuticals
Complete news archive for Centaur Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Centaur Pharmaceuticals
Centaur Pharmaceuticals was founded in 1978 and raised its 1st funding round 30 years after it was founded.
Centaur Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Centaur Pharmaceuticals is a funded company, having raised a total of $7M across 1 funding round to date. The company's 1st funding round was a Series A of $7M, raised on May 2008.
Centaur Pharmaceuticals has 3,523 employees.
The primary company behind Centaur Pharmaceuticals, Centaur Pharmaceuticals Private Limited, reported revenue of ₹1,060 Cr for FY 2025, up 22% year on year.
Centaur Pharmaceuticals is involved in the development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms (FDF). The company operates across various therapeutic areas including ENT, pediatrics, ophthalmology, neurology, nephrology, diabetology, and cardiology. Comprehensive solutions are provided through synergies in RD, clinical research, and contract research and manufacturing services (CRAM). Facilities are maintained in multiple locations across India to support its integrated pharmaceutical value chain. End-to-end solutions are offered to prestigious partners in the global pharmaceutical industry.
Centaur Pharmaceuticals's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
Centaur Pharmaceuticals offers API Solutions, Formulations, and Clinical Research.
Centaur Pharmaceuticals has 1 investor. Key investors include SIDBI Venture Capital.
The valuation of Centaur Pharmaceuticals is $22.55M as of May 2008.
Centaur Pharmaceuticals operates through Centaur Pharmaceuticals Private Limited.
The legal entities of Centaur Pharmaceuticals currently have 8 directors, including Sharadchandra Damodar Abhyankar, Albert Tauro, Pritam Maruti Khawale and others.